REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION. Global Journal of Public Health Medicine, [S. l.], v. 7, n. 1, p. 208–215, 2025. DOI: 10.37557/gjphm.v7i1.336. Disponível em: https://gjphm.org/index.php/gjphm/article/view/336. Acesso em: 25 may. 2026.